Viridian Therapeutics, Inc. · NASDAQ:VRDN

Fairmount Funds Management LLC reported a 15.14% stake in Viridian Therapeutics, Inc. (Schedule 13D/A)

Event Oct 23, 2025 · Filed Oct 27, 2025

Fairmount Funds Management LLC reported a 15.14% stake in Viridian Therapeutics, Inc., 16,025,330 shares, with active intent on Oct 23, 2025. Filed Oct 27, 2025 (Schedule 13D/A).

Stake
15.14%
Shares
16,025,330
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Fairmount Funds Management LLC15.14%16,025,330
Fairmount Healthcare Fund II GP LLC15.14%16,025,330

Source

View original at SEC

Related